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The preceding paper described  the induction and isolation of cell mutants 
derived from a  single clone of virus-transformed, nonproducer (NP) 1 cells (1). 
This paper presents the characterization of these mutants with regard to the 
relationship between tumorigenesis and presence of sarcoma virus genome. 
Materials and Methods 
General.--Cell lines including  those produced by  5'-bromodeoxyuridine  (BrdU) muta- 
genesis were described in the previous paper (1). The complement-fixation (CF) test for mouse 
gs antigen has been described previously (2). The assay of RNA-dependent DNA polymerase 
in culture fluid by use of the synthetic polymer, rA: dT12, was previously reported (3). Rescue 
of the sarcoma genome by superinfection with helper virus was done as previously described 
(4). A more sensitive rescue technique, using Sendal virus to fuse cells replicating helper virus 
and test cells was also employed (5). The XC test for mouse Type C virus was performed as 
described by Rowe et al. (6). 
Chromosome Analysis.--Growing cells were treated for 4-18 h with 0.2 #g/ml of colchicine. 
Cells arrested in metaphase were removed by shaking, then centrifuged at 1,000g for 5 rain, 
resuspended in 1% sodium citrate for 20 rain at 37°C, recentrifuged, and finally fixed in freshly 
prepared glacial acetic acid:methanol (1:3). Chromosome preparations were made from the 
suspension and air dried. After staining with Giemsa and mounting, well-spread metaphases 
were photographed and the chromosome number determined. 
RESULTS 
Detection  of  Viral  Markers.  Mouse  Type  C  Virus  gs  A ntigen.--Mouse  gs 
antigen was not detectable by the CF test in any of the virus negative mutant 
cells. In contrast, the M-57-1 and M-58-4 cell lines which were found to shed 
virus, contained gs antigen in cellular and culture fluid extracts (Table I). 
Biological  Activity  of  Type  C  Partides.--The  Type  C  particles  shed  from 
M-57-1  and  M-58-4  cells  contained  gs  antigen  and  RNA-dependent DNA 
polymerase activity, induced syncytium formation when plated with XC cells, 
and showed  focus  forming activity on both NIH  Swiss and BALB/c mouse 
embryo cells  (Table I  and Fig.  1).  In general higher titers were  obtained on 
1  Abbreviations used in this paper: BrdU, 5'-bromodeoxyuridine; H(MSV), Harvey strain 
of murine sarcoma virus; .¥IuLV, murine leukemia virus; NP, nonproducer. 
364  THE  JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 138, 1973 tIATANAKA,  KLEIN,  LONG~ AND  GILDEN  365 
BALB/c  cells.  These  results indicated that  the  Type  C  particles shed  from 
M-57-1 and M-58-4 were infectious sarcoma viruses with no clear indication of 
either N- or B-tropism (7). 
Rescue of Sarcoma Genome  from the Virus-Free Mutants.--As shown in Table I, 
the nontumorigenic cell line M-43-2 did contain a  rescuable sarcoma genome, 
while the  tumorigenic mutant M-50 did not yield sarcoma virus in repeated 
rescue attempts by direct superinfection. With the more sensitive fusion rescue 
TABLE I 
Presence of Viral Markers in the Cell Mutants 
Cell type  Cell line 
gs Antigen  RNA-DNA  polymerase  Sarcoma  genome rescue 
Culture  Culture fluid  --Helper  +Helper  Cell  fluid 
Normal  B/3T3  0*  0J;  0,  0]l  0¶ 
Tumorigenic  NP  0  0  0  0  100 
A  M-50  0  0  0  0  0 
B  M-57d  32  4  1,312  76  -- 
C  M-43-2  0  0  0  0  2,600 
I)  M-584  32  4  855  340  -- 
* Number shows dilution of monospecific mouse gs antiserum demonstrating  4+  CF 
reaction with 2 U of complement against 50 #g of cell extract protein. 
The same CF test against particles from 25X or/zl of 20-fold concentrated culture media. 
§ Assay was performed as described previously (3). Average CPM from three to five plates 
by the following methods: 0.1 ml of culture fluid after low centrifugation was incubated with 
an equal volume of reaction mixture at 37°C for 30 mill. The reaction  mixture was then 
treated with cold 10% trichloroacetic acid and the acid insoluble material was collected on 
Millipore filter papers  (Millipore Corp., Bedford, Mass.);  the radioactivity  was determined 
in an LS-250 scintillation counter (Beckman Instruments, Inc., Palo Alto, Calif.). 
II Focus-forming units per milliliter culture media after  5 day infection on NIH Swiss 
mouse embryo fibroblasts. 
¶ The test cells were infected with 10  ~ endpoint dilution of RLV. 3 days postinfection, 
culture medium was filtered through a 0.45 # HA Millipore filter and 0.5 ml of the filtrate 
was put on NIH Swiss mouse embryo fibroblasts. 5 days later the foci were counted. 
technique, the M-50 cell line did yield sarcoma virus, but at levels 1/~ 5 that of 
parental NP cells. Preparations were assayed on both BALB/c and NIH Swiss 
cell lines with equivalent results. 
Superinfection.--The  nonshedding mutants, M-50 and M-43-2, were super- 
infectable by the Harvey strain of murine sarcoma virus [H(MSV)] or murine 
leukemia virus (MuLV). H(MSV) superinfection caused typical transformation 
in  these  mutant cells  (Fig.  2).  Although MuLV  infected M-43-2  cells  shed 
infectious sarcoma virus, they became flatter in appearance. 
Chromosome  Analysis.--The  number of  chromosomes  was  determined for 
each of the cell lines; frequency distributions compared to their progenitor cells 
are shown in Table II. BALB/3T3 has a subtetraploid mode (91% of the cells) FIG.  1. XC cell  syncytium formation with mutant cells shedding Type C  viruses.  (a) XC 
cell syncytium formation with M-57-1 cells.  (b) XC  cell syncytium formation with M-58-4 
cells.  Magnification 1,400X. FIG. 2. Morphological  changes of mutant cells after superinfection by leukemia and sarcoma 
viruses. (a) M-50 cells;  (b) M-50 cells plus RLV; (c) M-50 cells plus (MSV),  Five days post- 
infection; (d)  M-43-2  cells;  (e)  M-43-2  cells plus RLV; (f) M-43-2 cells plus H(MSV),  Five 
days postinfection. Magnification 218X. 368  MUTANTS  OF  NP  CELLS 
TABLE II 
Chromosome Analysis of BrdU-Induced  Cell Mutants 
Frequency distribution  of chromosome no.  Endo 
Cell lines  Passage no.  Modal  no.  redupli- 
i>70  71-80  81-90  91-100  101-120  121-140  cation 
% 
B/3T3  > i00  74  9 
NP  >100  84  5  25  50  20 
>100  84  2  29  54  6  2  7 
>100  84  14  72  9  5 
M-50  30  91  8  38  38  8  8 
45  86  9  9  60  22 
M-57-1  35  78  14  59  27 
50  71 
M-43-2  30  138  27  65  8 
45  135  5  86  9 
M-58-4  30  76  7  79  7 
The details are described  in Methods. 40-60 cells were counted to get the chromosome 
number. 
with a stemline of 70-75 chromosomes and a  modal chromosome number of 74. 
The progenitor NP cells contain a stemline of 81-90 chromosomes with a modal 
number of 84. The modal number of the M-50 cell line after 45  passages was 
found to be 86,  essentially similar to the modal number of the progenitor NP 
cells, while the modal numbers  of M-57-1  after 50 passages  (71),  and M-58-4 
after 30 passages (76) are closer to that found for the normal progenitor BALB/ 
3T3  cells.  One  remarkable  difference is  the  modal  number  of  135  found  for 
M-43-2  cells after 45  passages. All cell lines contained at least one large acro- 
centric and one metacentric chromosome  (data not shown). 
Stability of the Viral Markers.--The relationship between the sarcoma genome 
and  the  maintenance  of  the  transformed  state  was  shown  by  studies  of  the 
M-50 cell line. This line was highly tumorigenic but did not contain a rescuable 
genome by usual superinfection techniques. However, rescue was obtained using 
a  more sensitive fusion rescue method  (5). To test for the stability of the non- 
rescue property (by direct superinfection), one of the tumors derived from the 
M-50 cells was explanted and  assayed. This line, designated M-50T,  behaved 
as the parental line except that it was possible to rescue the sarcoma genome 
from M-50T by superinfection. The possibility of a partial genetic reversion or 
alteration of some control at the phenotypic level may account for this result. 
Tumor  derived  from  the  M-57-1  cell  line  retained  the  properties  of  the 
parental cell. When  explanted  in vitro,  these  tumors  continued  to produce a 
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The M-43-2 cell line was generally nontumorigenic and did not shed virus, 
however, cells inoculated at passage  15 produced a  small static tumor in one 
mouse after a 30 day latent period. This tumor line, M-43-2T, when explanted 
began to shed sarcoma virus in similar fashion to the M-57-1  cells.  From the 
chromosome analysis it was clear that the tumor was derived from the M-43-2 
cell line (modal number 135 each). 
One of the nontumorigenic mutant virus producing cell lines, M-58-4, became 
tumorigenic after long-term passage in vitro. At passage 48, 10  ~ cells produced 
an 80% tumor incidence in 14 days, while 104 cells produced a 20%  incidence 
in  36  days.  Thus,  the  high  passage  cell  designated  M-58-4-48  is  similar  to 
M-57-1, but has a lower oncogenic potential. The available mutants in group C 
(virus  shedding,  nonmalignant)  are  early  passages  (10-30)  of  M-58-4  and 
M-58-2, which has still not produced tumors at high passage levels. 
DISCUSSION 
Activation of an N-tropic sarcoma virus by BrdU from the progenitor NP 
cell line used in these studies has been reported by Aaronson (8). Results with 
M-57-1 and M-58-4 cell lines are in agreement with this observation except the 
tropism of the induced virus appeared to be NB-tropic; however, the cells used 
for our assays were not tested with standard N and B viruses. Stephenson et al. 
(9) reported that natural reversion of NP cells was quite rare, while reversion of 
S+L--  cells appeared quite often (10). S+L--  cells contain gs antigen, shed 
Type C particles with deficient RNA-dependent DNA polymerase activity, and 
do contain a rescuable sarcoma genome (11-13). 
Recently, Fischinger et al.  (10,  14)  reported that all of the flat revertants 
isolated from cloned transformed mouse 3T3 cells lacked a rescuable sarcoma 
genome and did not produce Type C particles. The M-50 cell line partially cor- 
responds  to  this  type  of  flat  revertant  which  can  be  isolated  without  any 
mutagenic treatment (10,  14). The M-50 line is however as tumorigenic as its 
NP cell progenitor. The tumorigenicity of flat revertants has not been reported 
(10,  14). In contrast to the M-50 type of flat mutant, the M-43-2 cell line has 
an  easily rescuable  sarcoma  genome, but  thus  far does not produce  tumors 
in vivo. 
Several papers have described a relationship between chromosome constitu- 
tion and the occurrence of flat revertants  (15-19).  Reversion of transformed 
cells to those exhibiting growth control was associated with a large increase in 
chromosome number, while reversion back to lack of growth control resulted 
in a  return to the original chromosome complement (15,  16,  19).  Results ob- 
tained with the M-43-2 cell line are consistent with this type of reversion since 
it had a modal number of 135 chromosomes, was flat in appearance, and non- 
tumorigenic in vivo. 
Suppression of tumorigenicity by BrdU treatment of mouse melanoma cells 
has been reported (20). This however, does not appear to be a necessary con- 
sequence of BrdU treatment of all tumor cell types, since in the present studies, 370  MUTANTS  OF  NP  CELLS 
variant cell  lines retaining oncogenic potential were obtained.  These included 
both particle producing and nonproducing derivatives. 
It  is  worthwhile  to  note  that  rescuabilitv  of  sarcoma  genome  does  not 
directly correlate with tumorigenicity. Although ability to rescue the sarcoma 
gene certainly proves the existence of the genome in cells, it does not guarantee 
phenotypic expression of the genorne. It is possible that the rescuable sarcoma 
gene in M-43-2 cells is subject to some cellular control mechanism which pre- 
vents the expression of malignant properties. On the other hand, the M-50 cell 
line is tumorigenic,  but possesses a  sarcoma genome which was not rescuable 
by superinfection. Its presence was however shown by fusion-rescue, but still 
with relatively low yield. A  tumor cell  line  (M-50T)  derived  from M-50  did 
possess a sarcoma genome rescuable by direct superinfection. The mechanism 
of control of the "rescue" phenotype is a present obscure; however, it does not 
appear to be based on virus exclusion since helper MuLV did replicate in M-50 
cells. 
Further evidence for cellular control of a potentially malignant cell contain- 
ing  the  sarcoma  genome  was  obtained  with  the  nontumorigenic  mutants 
M-58-4 and M-43-2. In both cases, tumorigenic mutants could be derived from 
these lines;  in one case,  after high  cell passage  (M-58-4)  in vitro,  and in  the 
other from an individual small static tumor obtained with the cell line (M-43-2). 
The cell lines described in these studies should be useful for identification of 
cellular  control  mechanisms  operative  in  regulation  of  oncogenicity  of  cells 
carrying a sarcoma virus genome. 
SUMMARY 
Tumorigenic  and  nontumorigenic  mutants  induced  by  a  single  5'-bromo- 
deoxyuridine  (BrdU)  treatment  of a  nonproducer  (NP)  tumorigenic cell  line 
were isolated and characterized. Among the cloned derivatives were examples 
of  virus-free  and  sarcoma  virus-producing  cell  lines.  Oncogenicity  did  not 
correlate with production of virus or ease of rescue of the sarcoma genome. All 
lines,  including  nononcogenic  derivatives,  retained  the  sarcoma genome. 
Phenotypic reversion of some cell mutants was observed after in vivo inocula- 
tion  or long term in  vitro cultivation.  The  M-50T  cell  line,  obtained from a 
tumor induced by M-50 cells,  had a sarcoma genome rescuable by direct super- 
infection; this was only achieved with parental M-50 cells by a cell fusion rescue 
technique. The M-43-2T cell, obtained from a single small static tumor induced 
by  otherwise  nononcogenic  M-43-2  cells,  shed  sarcoma  virus  and  became 
tumorigenic.  M-58-4-48  became  tumorigenic  after passage  48  of the  M-58-4 
line,  which  was originally nontumorigenic.  These observations  of  phenotypic 
reversion  demonstrate  that  the  presence  of  the  sarcoma  gene  in  cells  is  an 
essential but not sufficient condition of tumorigenesis. HATANAKA, KLEIN,  LONG, AND  GILDEN  371 
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